17.30-18.00 Why a gastroenterologist should treat obesity?
Cristina Cijevschi
18.00-18.30 The Physician and Pharmacist’s Hub – unique concept in Oltenia
Tudorel Ciurea
Day II (11th of April 2025)
CARDIOLOGY HALL – 2nd Floor
08:00
Cardiology at the Intersection of Specialties Chairmen: Ruxandra Jurcuț, Constantin Militaru
8:00-8:20 CardioRheumatology: Cardiac involvement in autoimmune diseases Cristina Florescu
8:20-8:40 CardioObstetrics: Hypertension in pregnancy Ana Maria Balahura
8:40-9:00 CardioOncology: Cardiovascular risk stratification in oncology patients Ruxandra Jurcuț
9:00-9:20 CardioGenetics: Genetic testing in cardiomyopathies Sebastian Militaru
9:20-9:30 Take home messages Ruxandra Jurcuț, Constantin Militaru
09:30
Inhibition of the renin-angiotensin-aldosterone system in current hypertension guidelines (Servier) Constantin Militaru
09:45
The vicious circle of control: Strategies for effectively reducing blood pressure in patients with diabetes (Servier) Ionuț Donoiu
10:00
Cardiovascular health map: Strategies for patients with uncontrolled LDL-C (Sanofi) Octavian Istrătoaie
10:30
Harmonizing the heart - Role of betablockers in hypertension (Merck) Eugen Țieranu/Radu Stăvaru
11:00
Break
11:30
Interventional Cardiology - Beyond the Limits Chairmen: Dan Deleanu, Eugen Țieranu
11:30-11:50 Heart valve interventional procedures Dan Deleanu
11:50-12:10 CHIP cases: Can PCI save the day? Eugen Țieranu
12:10-12:30 Imaging and Physiology in Interventional Cardiology Ovidiu Mitu
12:30-12:50 CTO: When and how to do? Cristian Militaru
12:50-13:00 Take home messages Dan Deleanu, Eugen Țieranu
13:00
Lunch break
14:00
Choosing the optimal DOAC in the frail patient with AF (Berlin Chemie) Octavian Istrătoaie
14:30
Future Perspectives in Cardiac Surgery Chairmen: Horaţiu Moldovan, Victor Raicea
14:30-14:45 Endoscopic cardiac surgery – a road to the future Cătălin Badiu
14:45-15:00 Endoscopic access, an extra chance for mitral valve repair Marius Harpa
15:00-15:15 The history of extracorporeal circulation Liviu Moraru
15:15-15:30 Mitral valvuloplasty through minimal invasive approach Horaţiu Moldovan
15:30-15:45 Acute mitral regurgitation complicating myocardial infarction Victor Raicea
15:45
Xanirva 2,5 mg – Dual, extended protection in coronary and peripheral arterial disease (Zentiva) Eugen Țieranu
16:00
The role of metabolic therapies in cardiovascular pathology (Sun Wave) Oana Munteanu-Mirea
16:15
Arginine and Iron – The Synergistic Role in the Management of Cardiovascular Disease (Naturalis) Petre Ciobanu
16:30
Hypertrophic cardiomyopathy: new clinical evidence and updated guidelines for optimized management (BMS) Sebastian Militaru
16:45
Break
17:00
Arrhythmias in Obesity Chairmen: Cristian Stătescu, Radu Vătășescu
17:00-17:20 Arrhythmogenesis in obesity Adrian Ungureanu
17:20-17:40 Obesity and atrial fibrillation Cristian Stătescu
17:40-18:00 Obesity, malignant ventricular arrhythmias and sudden death Radu Vătășescu
18:00-18:20 Bradyarrhythmias in obese patients Georgică Târtea
18:20-18:40 Peripartum arrhythmias and the risks of weight gain Emilia Goanță
Day III (12th of April 2025)
CARDIOLOGY HALL – 2nd Floor
08:00
Interventional Cardiology Crossfire - Case-Based Debates Chairmen: Dan Deleanu, Eugen Țieranu
Discussions Panel: Cristian Militaru, Victor Raicea, Alexandru Rocşoreanu, Radu Stăvaru
09:40
8 years of Repatha in the coronary patient (Amgen) Ionuţ Donoiu
09:55
What remains hidden from the view? (Krka) Cristina Florescu
10:10
Anticoagulation: the balance between risk and benefit – current perspectives (Pfizer) Oana Munteanu-Mirea
10:30
Break
11:00
From now on, treating Obesity means Saving Lives! (Novo Nordisk) Chairman: Cătălina Poiana
Symphony of Semaglutide 2.4 mg: SELECT and STEP-HFpEF
Ionuț Donoiu
From SELECT to SCORE: Semaglutide's Journey
Dan Gaiță
11:45
Magnesium deficiency in cardiovascular pathology (Worwag) Camelia Diaconu
12:00
Dabigatran - the importance of anticoagulant treatment in patients with non-valvular atrial fibrillation (Gedeon Richter) Oana Munteanu-Mirea
12:20
Current perspectives in modern HF therapy. Sharing from clinical practice: when and how do we initiate Entresto in the patient with HFrEF? (Novartis) Eugen Țieranu
12:40
Optimal drug management of deep vein thrombosis (Pfizer) Cristina Florescu